As COVID-19 vaccines are distributed, individuals who are trying to get pregnant or pregnant may have questions about the vaccines. At the University of Massachusetts Medical School – Baystate, a group of experts (the Shared Decision-Making: COVID Vaccination in Pregnancy working group), created an aid to help individuals who are pregnant, lactating, or planning on becoming pregnant decide whether or not to receive an mRNA COVID-19 vaccine. These decision aids, currently available in 10 languages, will be updated on this post as more information. Additional information on the safety of COVID-19 vaccines in pregnancy can be found here.

Members of the Shared Decision-Making: COVID Vaccination in Pregnancy Working Group from the University of Massachusetts Medical School – Baystate

• Elizabeth Schoenfeld, MD, MS; Vice Chair of Research; Department of Emergency Medicine; practicing emergency medicine physician, Shared Decision-Making researcher, and decision aid designer.
• Kathaleen Barker, MD, FACOG; Assistant Professor of Obstetrics and Gynecology, Medical Director of Informatics for Women’s Health, Associate Director of Obstetrics
• Ashley Deutsch, MD; Director of Quality and Patient Safety, Department of Emergency Medicine, Baystate Medical Center – practicing emergency physician, currently breastfeeding
• Elizabeth Morgan, MD, MS; Assistant Professor, Division of Maternal-Fetal Medicine
• Corina Schoen, MD, FACOG; Assistant Professor of Obstetrics and Gynecology, Assistant Director of Obstetric Research; Division of Maternal-Fetal Medicine
• Liza Smith, MD; Assistant Professor of Emergency Medicine, practicing emergency medicine physician, medical educator, currently pregnant
• Lauren Westafer, DO, MPH, MS; Assistant Professor of Emergency Medicine, Research Fellowship Director; practicing emergency medicine physician, implementation science researcher, currently pregnant

References:

1. DeBolt CA, et al. Pregnant women with severe or critical COVID-19 have increased composite morbidity compared to
   non-pregnant matched controls. Am J Obstet 2020 Nov doi: 10.1016/j.ajog.2020.11.022
2. Adhikari EH, et al. Pregnancy outcomes among women with and without severe acute respiratory syndrome coronavirus
   2 infection. JAMA Network Open 2020 Nov 3(11):e2029256
3. DiMascio D, WAPM working group on COVID-19. Maternal and Perinatal Outcomes of Pregnancy Women with SARScoV-2 infection. Ultrasound Obstet Gynecol. 2020 Sept. doi: 10.1002/uog.23107.
4. Centers for Disease Control and Prevention. Update: Characteristics of Symptomatic Women of Reproductive Age with
   Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020.
   November 2020:1-7.
5. Abbasi J. COVID-19 and mRNA Vaccines—First Large Test for a New Approach. JAMA. 2020;324(12):1125–1127.
   doi:10.1001/jama.2020.16866
6. FDA Pfizer Briefing. https://www.fda.gov/media/144245/download
7. FDA Moderna Briefing. https://www.fda.gov/media/144434/download
8. https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-etr.html (Accessed Dec14, 2020)
9. CDC. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html (Accessed March 10, 2021)
10. SMFM statement on COVID vaccination in pregnancy: https://www.smfm.org/publications/339-society-for-maternal-fetalmedicine-smfm-statement-sars-cov-2-vaccination-in-pregnancy
11. https://www.acog.org/en/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-Pregnant-andLactating-Patients-Against-COVID-19 (Accessed December 14, 2020)
12. WHO. https://www.who.int/news-room/feature-stories/detail/the-moderna-covid-19-mrna-1273-vaccine-what-you-need-to-know
13. Mutambudzi M, Niedwiedz C, Macdonald EB, et al. Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occupational and Environmental Medicine Published Online First: 09 December doi: 10.1136/oemed-2020-106731
14. https://abm.memberclicks.net/abm-statement-considerations-for-covid-19-vaccination-in-lactation